Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
3.150
+0.010 (0.32%)
At close: May 12, 2025, 4:00 PM
3.120
-0.030 (-0.95%)
After-hours: May 12, 2025, 7:00 PM EDT
Phathom Pharmaceuticals Stock Forecast
PHAT's stock price has decreased by -66.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Phathom Pharmaceuticals stock have an average target of 17.8, with a low estimate of 5.00 and a high estimate of 28. The average target predicts an increase of 465.08% from the current stock price of 3.15.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Phathom Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | +58.73% | May 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | +280.95% | May 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $20 | Strong Buy | Maintains | $28 → $20 | +534.92% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +788.89% | Apr 21, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | +217.46% | Apr 17, 2025 |
Financial Forecast
Revenue This Year
166.72M
from 55.25M
Increased by 201.74%
Revenue Next Year
357.04M
from 166.72M
Increased by 114.16%
EPS This Year
-4.33
from -5.29
EPS Next Year
-2.15
from -4.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 180.6M | 400.2M | 751.5M | ||
| Avg | 166.7M | 357.0M | 603.7M | ||
| Low | 145.7M | 319.9M | 507.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 226.9% | 140.0% | 110.5% | ||
| Avg | 201.7% | 114.2% | 69.1% | ||
| Low | 163.8% | 91.9% | 42.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -4.01 | -1.48 | 1.16 | ||
| Avg | -4.33 | -2.15 | 0.18 | ||
| Low | -4.61 | -3.01 | -0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.